ZÁVADA, Jakub, Michal UHER, Katarina SISOL, Šárka FOREJTOVÁ, Kateřina JAROŠOVÁ, Heřman F. MANN, Jiří VENCOVSKÝ a Karel PAVELKA. A Tailored Approach to Reduce Dose of Anti-TNF Drugs Is Equally Effective, but Substantially Less Costly Than Standard Dosing in Patients with Ankylosing Spondylitis over One Year: A Propensity Score-Matched Cohort Study. In ARTHRITIS & RHEUMATOLOGY. 2014. ISSN 2326-5191. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{1299405, author = {Závada, Jakub and Uher, Michal and Sisol, Katarina and Forejtová, Šárka and Jarošová, Kateřina and Mann, Heřman F. and Vencovský, Jiří and Pavelka, Karel}, booktitle = {ARTHRITIS & RHEUMATOLOGY}, title = {A Tailored Approach to Reduce Dose of Anti-TNF Drugs Is Equally Effective, but Substantially Less Costly Than Standard Dosing in Patients with Ankylosing Spondylitis over One Year: A Propensity Score-Matched Cohort Study.}, year = {2014} }
TY - CONF ID - 1299405 AU - Závada, Jakub - Uher, Michal - Sisol, Katarina - Forejtová, Šárka - Jarošová, Kateřina - Mann, Heřman F. - Vencovský, Jiří - Pavelka, Karel PY - 2014 TI - A Tailored Approach to Reduce Dose of Anti-TNF Drugs Is Equally Effective, but Substantially Less Costly Than Standard Dosing in Patients with Ankylosing Spondylitis over One Year: A Propensity Score-Matched Cohort Study. ER -
ZÁVADA, Jakub, Michal UHER, Katarina SISOL, Šárka FOREJTOVÁ, Kateřina JAROŠOVÁ, Heřman F. MANN, Jiří VENCOVSKÝ a Karel PAVELKA. A Tailored Approach to Reduce Dose of Anti-TNF Drugs Is Equally Effective, but Substantially Less Costly Than Standard Dosing in Patients with Ankylosing Spondylitis over One Year: A Propensity Score-Matched Cohort Study. In \textit{ARTHRITIS \&{} RHEUMATOLOGY}. 2014. ISSN~2326-5191.
|